Mechanistic understanding of HPK1 inhibition on enhanced human T cell activation and tumor immunity in a syngeneic model.

被引：0
|
作者：
Ciccone, David [1 ]
Lazari, Vad [2 ]
Linney, Ian [2 ]
Briggs, Michael [2 ]
Carreiro, Samantha [1 ]
Loh, Christine [1 ]
Tummino, Peter [1 ]
McElwee, Joshua [1 ]
Collis, Alan [1 ]
Kaila, Neelu [1 ]
机构：
[1] Nimbus Therapeut, Cambridge, MA USA
[2] Charles River Labs, Chesterford Res Pk, Saffron Walden, Essex, England
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1649
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A highly potent HPK1 inhibitor augments immune cell activation and anti-tumor immunity in a syngeneic tumor mouse model
    Liu, Hao
    Wu, Lei
    Feng, Song
    Huang, Wei
    Li, Huijuan
    Lin, Jing
    Liu, Yangyang
    Mei, Liufeng
    Ren, Baoqi
    Xie, Julie
    Yao, Lili
    Zhong, Wenge
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [2] A highly selective and potent HPK1 inhibitor enhances immune cell activation and induces robust tumor growth inhibition in a murine syngeneic tumor model
    Ciccone, D.
    Lazari, V.
    Linney, I.
    Briggs, M.
    Carreiro, S.
    Waddell, I.
    Hill, C.
    Loh, C.
    Tummino, P.
    Collis, A.
    Kaila, N.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S20 - S20
  • [3] A HIGHLY SELECTIVE AND POTENT HPK1 INHIBITOR ENHANCES IMMUNE CELL ACTIVATION AND INDUCES ROBUST TUMOR GROWTH INHIBITION IN A MURINE SYNGENEIC TUMOR MODEL
    Ciccone, David
    Lazari, Vad
    Linney, Ian
    Briggs, Michael
    Carreiro, Samantha
    McElwee, Joshua
    Waddell, Ian
    Hill, Chris
    Loh, Christine
    Tummino, Peter
    Collis, Alan
    Kaila, Neelu
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A411 - A411
  • [4] HPK1 inhibition enhances T cell activation and relieves the immunosuppressive phenotype of inhibitory signals found in the tumor microenvironment
    Singh, Rajesh K.
    Rayaji, Rameshwari
    Patel, Bindi
    Zhang, Kristen
    Marubayashi, Sachie
    Cho, Soonweng
    Garrido-Shaqfeh, Stefan
    Kulusich, Joseph
    Meleza, Cesar
    Tibrewal, Nidhi
    Thomas, Joice
    Nareddy, Pradeep
    Sharif, Ehesan
    Zhao, Sharon
    Green, David
    Leleti, Manmohan R.
    Powers, Jay P.
    DiRenzo, Daniel
    Walters, Matthew J.
    CANCER RESEARCH, 2022, 82 (12)
  • [5] Releasing the break on T cell activation through novel small molecule inhibition of HPK1
    Shen, Minhui
    Bommakanti, Gayathri
    Mele, Deanna
    Grimster, Neil
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [6] Pharmacologic inhibition of HPK1 kinase activity enhances immune cell activation and T cell mediated anti-tumor activity
    Lee, Jacob S.
    Toy, Pamela
    Min-Oo, Gundula
    Lee, Tony
    Salvo, Patrick
    Belzile, JeanPhilippe
    Clancy, Sheila
    Nazareno, Jonathan
    Xu, Mengshu
    Xing, Weimei
    Giacomini, Marilyn
    Santos, Rex
    Stapleton, Lance
    Wang, Adele
    Juric, Vladislava
    Mitchell, Scott A.
    Kuhne, Michelle
    CANCER RESEARCH, 2022, 82 (12)
  • [7] HPK1 kinase inhibitor: a sufficient approach to target HPK1 to modulate T cell activation in cancer immunotherapy compared with degraders
    Wang, Qin
    Zhu, Xinyi
    Li, Jing
    Xu, Sanjia
    Wang, Ali
    Zhang, Xinwen
    Wang, Xingxing
    Cai, Xiaopeng
    Xing, Haimei
    Liu, Ye
    Liu, Xuesong
    Wang, Zhiwei
    Wang, Lai
    Yuan, Xi
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [8] BB5523, a multiple kinase inhibitor with HPK1, VEGFR2 and TNIK inhibition, enhanced antitumor immunity in tumor models
    Duan, Gongping
    Li, Min
    Zhang, Puyong
    Hua, Wei
    Hao, Enlun
    Wang, Shipeng
    Ma, Xiaoyi
    Wang, Junheng
    Wei, Lijie
    Zhang, Xingmin
    CANCER RESEARCH, 2024, 84 (06)
  • [9] The role of HPK1 in the regulation of T cell function and anti-tumor immune activity
    Chen, Yaoyu
    Rios-Doria, Jonathan
    Pusey, Michelle
    Lasky, Kerri
    Ye, Min
    Thekkat, Pramod
    Gallagher, Karen
    Stump, Kristine
    Conlen, Patricia
    Gardiner, Christine
    Wang, Hui
    Sokolsky, Alexander
    Rupar, Mark
    Lin, Luping
    Behshad, Elham
    Covington, Maryanne
    Koblish, Holly
    Vechorkin, Oleg
    Yao, Wenqing
    Kim, Sunkyu
    Chen, Yingnan
    CANCER RESEARCH, 2020, 80 (16)
  • [10] HPK1 inhibits CD8+T cell effector gene expression following T cell activation
    Ames, Rachel Y.
    Zhao, Rongqi
    Mace, Parker
    Grant, Adam
    Xie, Guorui
    Milestone, Heather
    Grandcolas, Molly
    Fang, Eva
    Kiosea, Nicolae
    Wong, Stephen
    Brovarney, Martin
    Jacobson, Scott
    Nebalasca, Danilo
    Arguello, Jorge
    Gomez, Blanca
    Kandala, Hiranmayee
    Ko, Michelle Y.
    Nguyen, Lan
    Robles, Omar
    Shibuya, Grant
    Shakhmin, Anton A.
    Tivitmahaisoon, Parcharee
    Vi-Anh Vu
    Younai, Ashkaan
    Zibinsky, Mikhail
    Subramanyam, Babu
    Poon, Daniel
    Ghomi, Mohsen Sabouri
    Wustrow, David J.
    Kassner, Paul D.
    Katibah, George E.
    Brockstedt, Dirk G.
    CANCER RESEARCH, 2024, 84 (06)
12345